Announce Date | 08/11/2025 |
EPS Normalized Actual | $-0.36 (Miss by $-0.24316) |
EPS GAAP Actual | $-0.36 (Miss by $-0.24316) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 12/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0 |
EPS GAAP Estimate | $0 |
Revenue Estimate | $0.003B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2024 (Jun 2024) | -0.16 | -0.16 | 0B | -INF% | 0M |
FQ3 2024 (Sep 2024) | 0.0111 | 0.0111 | 1.2E-5B | 100% | 0.01M |
FQ4 2024 (Dec 2024) | -0.45 | -0.45 | 0.00025B | 100% | 0.25M |
FQ1 2025 (Mar 2025) | -1.55 | -1.55 | 0B | NAN% | 0M |
FQ2 2025 (Jun 2025) | -0.36 | -0.36 | 0B | NAN% | -3M |
FQ1 2024 (Mar 2024) | -0.16 | -0.16 | 0B | NAN% | 0M |
FQ4 2023 (Dec 2023) | 0.32 | 0.32 | 0B | NAN% | 0M |
FQ2 2023 (Jun 2023) | -1.9 | -1.9 | 0.000125B | 100% | 0.13M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.003B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 0 | -- | 0 | 0 | 2 |
FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 0 |
FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 0 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 0 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
FQ4 2026 (Dec 2026) | 0 | -- | 0 | 0 | 0 |
FQ3 2026 (Sep 2026) | 0 | -- | 0 | 0 | 0 |
FQ2 2026 (Jun 2026) | 0 | INF | 0 | 0 | 0 |
FQ1 2026 (Mar 2026) | 0 | INF | 0 | 0 | 0 |
FQ4 2025 (Dec 2025) | 0 | INF | 0 | 0 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ4 2027 (Dec 2027) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ3 2027 (Sep 2027) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ2 2027 (Jun 2027) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ1 2027 (Mar 2027) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ4 2026 (Dec 2026) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ3 2026 (Sep 2026) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ2 2026 (Jun 2026) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ1 2026 (Mar 2026) | 0B | -- | 0B | 0B | 0 |
FQ4 2025 (Dec 2025) | 0B | 91.67 | 0B | 0B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
3
Revenue # of Misses
1
Revenue # of in-lines
4
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2024 (Jun 2024) | -0.16 | -0.16 | 100% | |
FQ3 2024 (Sep 2024) | 0.0111 | 0.0111 | 100% | |
FQ4 2024 (Dec 2024) | -0.45 | -0.45 | 100% | |
FQ1 2025 (Mar 2025) | -1.55 | -1.55 | 100% | |
FQ2 2025 (Jun 2025) | 0 | -0.36 | -0.36 | 100% |
FQ1 2024 (Mar 2024) | -0.16 | -0.16 | 100% | |
FQ4 2023 (Dec 2023) | 0.32 | 0.32 | 100% | |
FQ2 2023 (Jun 2023) | -1.9 | -1.9 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
FQ3 2024 (Sep 2024) | $0B | $0B | $0.01M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0B | $0.25M | 100% |
FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
FQ2 2025 (Jun 2025) | $0B | $0B | $-3M | -INF% |
FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ2 2023 (Jun 2023) | $0B | $0B | $0.13M | 100% |